L. Boiocchi

发表

marrow fibrosis in chronic idiopathic myelofibrosis Prognostic implications of the European consensus for grading of bone

U. Gianelli, N. Fracchiolla, A. Iurlo, 2013 .

Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis.

U. Gianelli, N. Fracchiolla, A. Iurlo, 2008, Blood.

Clinicopathological and molecular features of SF3B1-mutated myeloproliferative neoplasms.

A. Iafrate, W. Wong, D. Dias-Santagata, 2019, Human pathology.

Clonal reticulohistiocytosis of the skin and bone marrow associated with systemic mastocytosis and acute myeloid leukaemia

C. Augello, E. Berti, U. Gianelli, 2017, Histopathology.

Human glioma tumors express high levels of the chemokine receptor CX3CR1.

P. Allavena, A. Mantovani, S. Pesce, 2010, European cytokine network.

Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents

Xingmin Feng, J. Bussel, H. Hasselbalch, 2011, British journal of haematology.

Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and mild reticulin fibrosis but not other stromal abnormalities

J. Bussel, W. Ghanima, A. Orazi, 2012, Modern Pathology.

Composite chronic lymphocytic leukemia/small lymphocytic lymphoma and follicular lymphoma are biclonal lymphomas: a report of two cases.

W. Tam, D. Knowles, S. Mathew, 2012, American journal of clinical pathology.

Correlation of p53 immunohistochemistry with TP53 mutational status and overall survival in newly diagnosed acute myeloid leukaemia

A. Fathi, A. Brunner, V. Nardi, 2022, Histopathology.

Bone marrow fibrosis in 66 patients with immune thrombocytopenia treated with thrombopoietin-receptor agonists: a single-center, long-term follow-up

J. Bussel, W. Ghanima, A. Orazi, 2014, Haematologica.

IgG4-related Lymphadenopathy

V. Deshpande, Jacob R. Bledsoe, K. Dresser, 2020, The American journal of surgical pathology.

Immune thrombocytopenia is associated with persistently deranged fibrosis-related seromarker profiles but low bone marrow fibrosis grades: A 2-year observational study on thrombopoietin receptor agonist treatment

Xingmin Feng, J. Bussel, P. Junker, 2019, Platelets.

Increased expression of vascular endothelial growth factor receptor 1 correlates with VEGF and microvessel density in Philadelphia chromosome-negative myeloproliferative neoplasms

S. Bosari, G. Coggi, U. Gianelli, 2011, Journal of Clinical Pathology.

Prostatic stromal tumor with fatal outcome in a young man: histopathological and immunohistochemical case presentation

G. Ceresoli, A. Santoro, M. Roncalli, 2010, Rare Tumors.

Clinical and morphologic features in five post-polycythemic myelofibrosis patients treated with ruxolitinib

A. Cortelezzi, U. Gianelli, E. Fermo, 2015, Annals of Hematology.

The long pentraxin PTX3 as a correlate of cancer-related inflammation and prognosis of malignancy in gliomas

C. Garlanda, A. Mantovani, M. Nebuloni, 2013, Journal of Neuroimmunology.

Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer

Kylie L. Gorringe, S. Loi, S. Lakhani, 2017, Modern Pathology.

BDCA-2 (CD303): a highly specific marker for normal and neoplastic plasmacytoid dendritic cells.

W. Vermi, S. Lonardi, F. Facchetti, 2013, Blood.

plasmacytoid dendritic cells BDCA-2 ( CD 303 ) : a highly specific marker for normal and neoplastic

W. Vermi, S. Lonardi, F. Facchetti, 2013 .

The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemia.

L. Kanz, L. Quintanilla‐Martinez, F. Fend, 2014, Human pathology.

A giant adrenal myelolipoma in a beta‐thalassemia major patient: Does ineffective erythropoiesis play a role?

E. Cassinerio, M. Cappellini, D. Dondossola, 2016, American journal of hematology.

Morphologic and cytogenetic differences between post-polycythemic myelofibrosis and primary myelofibrosis in fibrotic stage

D. Knowles, U. Gianelli, S. Mathew, 2013, Modern Pathology.

Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease

F. Fend, D. Knowles, I. Bonzheim, 2013, Modern Pathology.

The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations

C. Augello, U. Gianelli, I. Cortinovis, 2017, Modern Pathology.

Neutrophilic leukocytosis in advanced stage polycythemia vera: hematopathologic features and prognostic implications

F. Fend, D. Knowles, U. Gianelli, 2015, Modern Pathology.

Disease progression in myeloproliferative neoplasms: comparing patients in accelerated phase with those in chronic phase with increased blasts (<10%) or with other types of disease progression

J. Scandura, M. Ponzoni, P. Ronchi, 2020, Haematologica.

Tracheal melanic tattoo.

M. Mondoni, P. Carlucci, S. Centanni, 2011, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

High levels of vascular endothelial growth factor protein expression are associated with an increased risk of transfusion dependence in myelodysplastic syndromes.

S. Bosari, P. Bucciarelli, A. Cortelezzi, 2013, American journal of clinical pathology.

Occult recurrent breast cancer masquerading as thrombotic thrombocytopenic purpura

J. George, G. Soff, L. Boiocchi, 2022, American journal of hematology/oncology.

The long pentraxin PTX3 as a correlate of cancer-related inflammation and prognosis of malignancy in gliomas

C. Garlanda, M. Nebuloni, S. Gaini, 2013, Journal of Neuroimmunology.

Lenalidomide in patients with red blood cell transfusion-dependent myelodysplastic syndrome and del(5q): a single-centre “real-world” experience

G. Rossi, L. Imberti, A. Sottini, 2015, Leukemia & lymphoma.